Literature DB >> 24222659

Drug cessation in complex older adults: time for action.

Tischa J M van der Cammen1, Chakravarthi Rajkumar, Graziano Onder, Carolyn S Sterke, Mirko Petrovic.   

Abstract

BACKGROUND: general opinion is growing that drug cessation in complex older patients is warranted in certain situations. From a clinical viewpoint, drug cessation seems most warranted in four situations, i.e., falls, delirium, cognitive impairment and end-of-life situations. To date, little information about the effects of drug cessation in these four situations is available.
OBJECTIVES: to identify the effects and effectiveness of drug cessation on falls, delirium and cognitive impairment. For end-of-life situations, we reviewed cessation of inappropriate drug use.
METHODS: electronic databases were searched using MeSH terms and relevant keywords. Studies published in English were included if they evaluated the effects of drug cessation in older persons, aged ≥65 years, with falls, delirium or cognitive impairment; or cessation of inappropriate drug use in end-of-life situations.
RESULTS: we selected seven articles for falls, none for delirium, two for cognition and two for end-of-life situations. Withdrawal of psychotropics reduced fall rate; a prescribing modification programme for primary care physicians reduced fall risk. Withdrawal of psychotropics and a systematic reduction of polypharmacy resulted in an improvement of cognition. Very little rigorous research has been conducted on reducing inappropriate medications in patients approaching end of life.
CONCLUSION: little research has focussed on drug cessation. Available studies showed a beneficial impact of cessation of psychotropic drugs on falls and cognitive status. More research in this field is needed. The issue of systematic drug withdrawal in end-of-life cases is controversial, but is increasingly relevant in the face of rising numbers of older people of this clinical status.

Entities:  

Keywords:  cognitive impairment; delirium; drug cessation; end of life; falls; older adults; older people

Mesh:

Substances:

Year:  2013        PMID: 24222659     DOI: 10.1093/ageing/aft166

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  33 in total

1.  A Multicomponent Intervention to Optimize Psychotropic Drug Prescription in Elderly Nursing Home Residents: An Italian Multicenter, Prospective, Pilot Study.

Authors:  Luca Pasina; Alessandra Marengoni; Simona Ghibelli; Flavio Suardi; Codjo D Djade; Alessandro Nobili; Carlotta Franchi; Gianbattista Guerrini
Journal:  Drugs Aging       Date:  2016-02       Impact factor: 3.923

2.  Higher Fit-fOR-The-Aged (FORTA) Scores Comprising Medication Errors are Associated with Impaired Cognitive and Physical Function Tests in the VALFORTA Trial.

Authors:  Farhad Pazan; Heinrich Burkhardt; Helmut Frohnhofen; Christel Weiss; Christina Throm; Alexandra Kuhn-Thiel; Martin Wehling
Journal:  Drugs Aging       Date:  2019-03       Impact factor: 3.923

3.  The role of the OncPal deprescribing guideline in end-of-life care.

Authors:  Emily Reeve; Danijela Gnjidic; Sarah Hilmer
Journal:  Support Care Cancer       Date:  2014-09-24       Impact factor: 3.603

4.  Assessing an Interprofessional Polypharmacy and Deprescribing Educational Intervention for Primary Care Post-graduate Trainees: a Quantitative and Qualitative Evaluation.

Authors:  Marcia C Mecca; John M Thomas; Kristina M Niehoff; Anne Hyson; Sean M Jeffery; John Sellinger; Adam P Mecca; Peter H Van Ness; Terri R Fried; Rebecca Brienza
Journal:  J Gen Intern Med       Date:  2019-04-10       Impact factor: 5.128

5.  Elderly patients treated with psychotropic medicines admitted to hospital: associated characteristics and inappropriate use.

Authors:  Xavier Vidal; Antonia Agustí; Antoni Vallano; Francesc Formiga; Antonio Fernández Moyano; Juana García; Alfonso López-Soto; Nieves Ramírez-Duque; Olga H Torres; José Barbé; Antonio San-José
Journal:  Eur J Clin Pharmacol       Date:  2016-03-05       Impact factor: 2.953

6.  Psychoactive medication use among older community-dwelling Americans.

Authors:  Yara K Haddad; Feijun Luo; Mamta V Karani; Zachary A Marcum; Robin Lee
Journal:  J Am Pharm Assoc (2003)       Date:  2019-06-14

7.  Multidisciplinary perspectives on medication-related decision-making for people with advanced dementia living in long-term care: a critical incident analysis.

Authors:  Domenica Disalvo; Tim Luckett; Alexandra Bennett; Patricia M Davidson; Meera Agar
Journal:  Eur J Clin Pharmacol       Date:  2020-01-14       Impact factor: 2.953

Review 8.  A systems approach to identifying the challenges of implementing deprescribing in older adults across different health-care settings and countries: a narrative review.

Authors:  Mouna Sawan; Emily Reeve; Justin Turner; Adam Todd; Michael A Steinman; Mirko Petrovic; Danijela Gnjidic
Journal:  Expert Rev Clin Pharmacol       Date:  2020-02-27       Impact factor: 5.045

9.  Anticholinergic and sedative medications exposure in older patients: a cross-sectional study.

Authors:  Xiaolin Zhang; Shuang Zhou; Xinran Li; Weiwei Zhou; Ying Zhou; Yimin Cui; Xinmin Liu
Journal:  Int J Clin Pharm       Date:  2019-08-07

10.  Longitudinal evaluation of medication underuse in older outpatients and its association with quality of life.

Authors:  Andreas D Meid; Renate Quinzler; Andreas Groll; Beate Wild; Kai-Uwe Saum; Ben Schöttker; Dirk Heider; Hans-Helmut König; Hermann Brenner; Walter E Haefeli
Journal:  Eur J Clin Pharmacol       Date:  2016-03-29       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.